8-K - LIMX - Equibles

UNITEDSTATES

SECURITIESAND EXCHANGE COMMISSION

Washington,D.C. 20549

FORM8-K

CURRENTREPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report: March 30, 2021

BioLab Naturals, Inc.

(Exact name of registrant as specified in its charter)

Delaware	333-239640	84-2288662
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification Number)

7400 E. Crestline Circle, Suite 130, Greenwood Village, CO 80111

(Address of principal executive offices)

(720) 273-0433

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Title of each Class	Trading Symbol	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging Growth Company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

| 1 |

| --- |

SECTION7. REGULATION FD

Item7.01 Regulation FD Disclosure.

Press Release

The information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act regardless of any general incorporation language in such filing.

On March 30, 2021, the Company issued a press release. A copy of the press release is attached hereto as Exhibit 99.1.

SECTION9. FINANCIAL STATEMENTS AND EXHIBITS

Item9.01 – Financial Statements and Exhibits

The following exhibits are filed with this report on Form 8-K.

Exhibit Number	Exhibit
99.1	Press Release dated March 30, 2021

| 2 |

| --- |

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized.

BIOLAB NATURALS, INC.

By: /s/ W. Edward Nichols

__________________________

W. Edward Nichols, CEO

Date: March 31, 2021

| 3 |

| --- |

EXHIBIT99.1

BioLab Naturals, Inc., a Delaware corporation (BLAB: OTC) announces entry into a Lease/Purchase Agreement.

Denver, CO / Accesswire / March 30, 2021 / Bio Lab Naturals, Inc., a Delaware corporation, "BLAB" (OTCQB: BLAB), based in Denver, Colorado, desires to provide information to its investors and shareholders related to a Lease/Purchase Agreement dated March 24, 2021.

On March 24, 2021, BLAB, through its subsidiary, Prime Time Live, Inc. ("PTL"), entered into a Lease/Purchase Agreement (the "Agreement") with an unrelated third party, whereby PTL leased one of its corporate assets to such third party for a term of twelve months in exchange for $20,000 to be paid upon execution of the Agreement. In addition, PTL shall receive $9,000 per month during the remaining 11-month term of the Agreement, with a potential buyout option for the asset, for a total potential aggregate value of $235,000 over the term of the Agreement, which includes the lease price and the potential buyout value for the asset.

AboutBio Lab Naturals, Inc.

Our stock trades on OTC Markets under the symbol "BLAB". Operating primarily through PTL, we specialize in providing clients with high resolution mobile LED screens for entertainment, corporate, civic and sporting events that includes: (i) the lease of our soon to be newly refurbished 53’ trailer and our new state of the art 30' X 18' LED screen, with an accompanying MQ Whisper Watt generator that can power the LED screen for 50 hours, and therefore provide our clients with true portability, and (ii) the purchase and sale of such LED screens.

ForwardLooking Statements

This press release includes "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of BLAB (the "Company"). Forward-looking statements are based on the expectations, estimates, or projections of the Company's management as of the date of this press release. Although BLAB's management believes these expectations, estimates, or projections to be reasonable as of the date of this presentation, forward-looking statements are inherently subject to significant business risks, economic and competitive uncertainties, or other contingencies, which could cause the Company's actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause BLAB's actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" sections in the Company's filings with the Securities and Exchange Commission, including the risks set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 which is available for viewing on the SEC's EDGAR website. These forward-looking statements speak only as of the date of this press release and, except as required by law, BLAB specifically disclaims any obligation to update these forward-looking statements, even if new information becomes available in the future.

CONTACT:

Darrell Avey

720-883-7063